Literature DB >> 20518695

The role of ERCP in the management of bile leakage: endoscopic sphincterotomy versus biliary stenting.

Kemal Dolay1, Aliye Soylu, Ersan Aygun.   

Abstract

INTRODUCTION: Bile leakage is a common complication of cholecystectomy. The aim of this study was to compare endoscopic sphincterotomy (EST) and biliary stenting (BS) in the treatment of bile leaks after cholecystectomy. PATIENTS AND METHODS: Twenty-seven patients with bile leakage following cholecystectomy underwent endoscopic retrograde cholangiography (ERCP). Patients were randomized into two groups (EST and BS +/- EST), according to the initial therapeutic endoscopic intervention. The patients were allocated into subgroups once more, according to diameter of the common bile duct (CBD). Outcomes and efficacy of BS and EST on fistula closure and the time to fistula closure were investigated.
RESULTS: The median time between cholecystectomy and ERCP in the EST and BS groups was 6.45 +/- 3.41 and 4.50 +/- 1.99 days, respectively. The mean daily amount of biliary leakage in the EST and BS groups was 376.92 +/- 243.77 and 441.07 +/- 216.08 cc/day, respectively. The diameter of the distal part of CBD in the EST and BS groups was 9.07 +/- 3.84 and 8.28 +/- 4.04 mm, respectively. Mean fistula closure was achieved in 6.45 +/- 3.41 in 11 of 13 patients in the EST group and 4.50 +/- 1.99 days in the BS group in all patients. However, mean time of closure was significantly shorter in the BS 4.71 +/- 2.14 group, compared to EST (9.67 +/- 2.51), among patients with distal CBD diameter (< or =8 mm).
CONCLUSIONS: BS seems to be a more effective method than EST in the management of postcholecystectomy among patients with bile leakage and without CBD dilatation. BS might be the first-line treatment among such patients. However, further prospective, randomized, clinical trials regarding CBD dilatation are warranted.

Entities:  

Mesh:

Year:  2010        PMID: 20518695     DOI: 10.1089/lap.2009.0308

Source DB:  PubMed          Journal:  J Laparoendosc Adv Surg Tech A        ISSN: 1092-6429            Impact factor:   1.878


  8 in total

1.  Diagnostic value of Gd-EOB-DTPA-enhanced MR cholangiography in non-invasive detection of postoperative bile leakage.

Authors:  Melahat Kul; Ayşe Erden; Ebru Düşünceli Atman
Journal:  Br J Radiol       Date:  2017-02-09       Impact factor: 3.039

2.  Endoscopic Therapy of Biliary Injury After Cholecystectomy.

Authors:  Mia Rainio; Outi Lindström; Marianne Udd; Carola Haapamäki; Arno Nordin; Leena Kylänpää
Journal:  Dig Dis Sci       Date:  2017-09-25       Impact factor: 3.199

3.  Endoscopic Treatment of Biliary Leaks After Laparoscopic Cholecystectomy: Cut or Plug?

Authors:  Patrick G Brady; Pushpak Taunk
Journal:  Dig Dis Sci       Date:  2018-02       Impact factor: 3.199

4.  Endoscopic management of postcholecystectomy biliary leaks.

Authors:  Hemant Sharma; George Bird
Journal:  Frontline Gastroenterol       Date:  2011-08-31

Review 5.  ERCP licence in the context of medical practices, legal regulations, medical ethics and patient's rights in our country.

Authors:  Sezgin Yılmaz
Journal:  Turk J Surg       Date:  2022-03-28

6.  Biliary sphincterotomy is not required for bile duct stent placement.

Authors:  C Mel Wilcox; Hwasoon Kim; Jayapal Ramesh; Jessica Trevino; Shyam Varadarajulu
Journal:  Dig Endosc       Date:  2013-03-20       Impact factor: 7.559

7.  The reasonable therapeutic modality for biliary duct-to-duct anastomotic stricture after liver transplantation: ERCP or PTC?

Authors:  Hu Bowen; Guo Wenzhi; Wen Peihao; Shi Jihua; Zhang Shuijun
Journal:  Front Oncol       Date:  2022-09-29       Impact factor: 5.738

Review 8.  2020 WSES guidelines for the detection and management of bile duct injury during cholecystectomy.

Authors:  Nicola de'Angelis; Fausto Catena; Riccardo Memeo; Federico Coccolini; Aleix Martínez-Pérez; Oreste M Romeo; Belinda De Simone; Salomone Di Saverio; Raffaele Brustia; Rami Rhaiem; Tullio Piardi; Maria Conticchio; Francesco Marchegiani; Nassiba Beghdadi; Fikri M Abu-Zidan; Ruslan Alikhanov; Marc-Antoine Allard; Niccolò Allievi; Giuliana Amaddeo; Luca Ansaloni; Roland Andersson; Enrico Andolfi; Mohammad Azfar; Miklosh Bala; Amine Benkabbou; Offir Ben-Ishay; Giorgio Bianchi; Walter L Biffl; Francesco Brunetti; Maria Clotilde Carra; Daniel Casanova; Valerio Celentano; Marco Ceresoli; Osvaldo Chiara; Stefania Cimbanassi; Roberto Bini; Raul Coimbra; Gian Luigi de'Angelis; Francesco Decembrino; Andrea De Palma; Philip R de Reuver; Carlos Domingo; Christian Cotsoglou; Alessandro Ferrero; Gustavo P Fraga; Federica Gaiani; Federico Gheza; Angela Gurrado; Ewen Harrison; Angel Henriquez; Stefan Hofmeyr; Roberta Iadarola; Jeffry L Kashuk; Reza Kianmanesh; Andrew W Kirkpatrick; Yoram Kluger; Filippo Landi; Serena Langella; Real Lapointe; Bertrand Le Roy; Alain Luciani; Fernando Machado; Umberto Maggi; Ronald V Maier; Alain Chichom Mefire; Kazuhiro Hiramatsu; Carlos Ordoñez; Franca Patrizi; Manuel Planells; Andrew B Peitzman; Juan Pekolj; Fabiano Perdigao; Bruno M Pereira; Patrick Pessaux; Michele Pisano; Juan Carlos Puyana; Sandro Rizoli; Luca Portigliotti; Raffaele Romito; Boris Sakakushev; Behnam Sanei; Olivier Scatton; Mario Serradilla-Martin; Anne-Sophie Schneck; Mohammed Lamine Sissoko; Iradj Sobhani; Richard P Ten Broek; Mario Testini; Roberto Valinas; Giorgos Veloudis; Giulio Cesare Vitali; Dieter Weber; Luigi Zorcolo; Felice Giuliante; Paschalis Gavriilidis; David Fuks; Daniele Sommacale
Journal:  World J Emerg Surg       Date:  2021-06-10       Impact factor: 5.469

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.